Michaela Spence YOU? Author Swipe

Last 10y

Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada Open

David Garcia, G. Mau, Sumeet Singh, Michaela Spence, Morten Sall Jensen , et al. · 2025

Insulin icodec is a cost-effective treatment option for adult patients with T2D versus once daily basal insulin-analogues publicly reimbursed in Canada.

Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta‐Analysis Open

Lucio Gordan, Rohan Medhekar, Alex Z. Fu, Mostafa Shokoohi, Abril Oliva Ramirez , et al. · 2025

Daratumumab in combination with lenalidomide and dexamethasone (DRd) and bortezomib in combination with lenalidomide and dexamethasone (VRd) are guideline‐recommended preferred regimens for initial treatment of transplant‐ineligible (TIE) …